Therefore, we are exploring the possibility of FAP-CAR T cells in the treatment of pulmonary fibrosis and its mechanism of action, and corresponding progress has been made, which will be presented in subsequent articles. This evidence concerns the gene FAP and pulmonary fibrosis.